Santa Fe Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Santa Fe Partners’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-15,658	Closed	-$1.97M	–	309
2015 Q4	$1.97M	Buy	+15,658	New	+$1.89M	0.32%	125
2015 Q3	–	Sell	-8,778	Closed	-$1.08M	–	588
2015 Q2	$1.08M	Buy	+8,778	New	+$1.11M	0.15%	267
2014 Q4	–	Sell	-12,553	Closed	-$1.41M	–	610
2014 Q3	$1.41M	Buy	+12,553	New	+$1.2M	0.22%	196
2014 Q1	–	Sell	-15,885	Closed	-$1.18M	–	583
2013 Q4	$1.18M	Buy	+15,885	New	+$1.11M	0.19%	207

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Santa Fe Partners's VRTX Position: Q1 2016 in Review

Santa Fe Partners sold out of Vertex Pharmaceuticals (VRTX) in Q1 2016, closing a stake of 15,658 shares — an estimated $1.97M sold.

Santa Fe Partners first reported a position in VRTX in Q4 2013 and held it in 4 quarters. The position peaked at $1.97M in Q4 2015. 502 funds tracked by Wall St. Rank hold VRTX as of Q1 2016.

Santa Fe Partners reported no remaining Vertex Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Santa Fe Partners sold 15,658 Vertex Pharmaceuticals shares in Q1 2016, an estimated $1.97M.
Santa Fe Partners first reported a position in Vertex Pharmaceuticals in Q4 2013 and held it in 4 quarters.
Santa Fe Partners's Vertex Pharmaceuticals position peaked at $1.97M in Q4 2015.
502 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2016.

Based on Santa Fe Partners's 13F filing for Q1 2016.